eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 29/06/2010
SPC Kaolin and Morphine Mixture BP


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Kaolin and Morphine Mixture BP


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Ingredient

%w/v

Irradiated light kaolin BP

20

Morphine Hydrochloride Ph Eur

0.0092


Go to top of the page
3. PHARMACEUTICAL FORM

A slowly separating buff suspension with the odour and taste of chlorodyne.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the relief of occasional diarrhoea.

For oral administration.


Go to top of the page
4.2 Posology and method of administration

Adults and children over 12 years: 10ml (two teaspoonfuls) in water.

May be repeated three times a day until the condition is relieved.

Children under 12 years: Not recommended for children under 12 years.

Elderly: There is no need for dosage reduction in the elderly.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients. Respiratory depression, acute alcoholism, head injuries and conditions in which there is raised intracranial pressure. Impaired liver function.


Go to top of the page
4.4 Special warnings and precautions for use

Should be used with caution in patients with inflammatory or obstructive bowel disorders.

Keep all medicines out of the reach of children.

Warning: Do not exceed the stated dose.

If diarrhoea does not stop in 24 hours, talk to your doctor.

Suitable for the symptomatic relief of diarrhoea only. No substitute for rehydration therapy. Drink plenty of fluids if you have diarrhoea.

May cause drowsiness. If affected do not drive or operate machinery.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Clinically significant interactions may occur in patients taking maoi's concurrently or within 14 days of such treatment and these reactions may be serious. The depressant effects of morphine may enhance depressants of the central nervous system such as alcohol, hypnotics, sedatives and phenothiazines. The absorbent properties of kaolin may influence the gastrointestinal absorption of other drugs.


Go to top of the page
4.6 Pregnancy and lactation

The safety of kaolin and morphine during pregnancy and lactation has not been established, though no special precautions are thought necessary provided the recommended dose is taken.


Go to top of the page
4.7 Effects on ability to drive and use machines

Kaolin and morphine mixture may cause drowsiness in certain individuals and may therefore interfere with the ability to drive or operate machinery.


Go to top of the page
4.8 Undesirable effects

Common side effects which may occur include nausea, vomiting, constipation, drowsiness, dry mouth, sweating, facial flushing and miosis.


Go to top of the page
4.9 Overdose

Symptoms of overdosage may include nausea, vomiting, drowsiness, confusion, dry mouth, sweating, facial flushing, bradycardia, palpitations, orthostatic hypotension and miosis. Respiratory depression, circulatory failure, deepening coma and convulsions may also occur.

Treatment consists of emptying the stomach by aspiration and lavage. A saline purgative such as sodium sulphate, 30g in 250ml of water may be given to aid peristalsis.

The specific narcotic antagonist naloxone may be used to rapidly counteract the respiratory depression and coma. Otherwise treatment should be symptomatic and supportive.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Light kaolin is absorbent and when given orally absorbs toxic and other substances from the gastrointestinal tract and increases the bulk of the faeces.

Morphine in small doses increases tone and contraction in both the small and large bowel without analgesic effect and thereby delays intestinal transit.


Go to top of the page
5.2 Pharmacokinetic properties

Kaolin is not absorbed from the gastrointestinal tract. Morphine is absorbed from the gastrointestinal tract and undergoes significant first pass metabolism in the liver. Morphine is widely distributed.

Metabolism occurs in the liver, principally to morphine 3- and 6- glucuronides, although smaller amounts of morphine undergo n-demethylation and o-methylation. About 10% of morphine is secreted in the bile and eliminated in the faeces, while the remainder is excreted in the urine, mainly as conjugates.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Sodium bicarbonate

Black treacle

Liquorice liquid extract

Peppermint oil

Alcohol 96%

Anaesthetic ether

Chloroform

Liquid sugar

Purified water


Go to top of the page
6.2 Incompatibilities

Not applicable


Go to top of the page
6.3 Shelf life

36 months


Go to top of the page
6.4 Special precautions for storage

Keep tightly closed


Go to top of the page
6.5 Nature and contents of container

A 2000ml amber-coloured glass bottle with a wadless polypropylene cap.

A 200ml amber-coloured glass bottle, screwneck and a pilfer-proof aluminium roll-on cap with a PVC flowed in liner or triseal (LDPE/EPE/LDPE) liner.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

Trading as: BCM


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0014/5783R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

30 November 1990


Go to top of the page
10. DATE OF REVISION OF THE TEXT

January 2010



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/13915/SPC/


Active Ingredients/Generics

 
   kaolin light
   morphine hydrochloride